AMPERSAND CAPITAL PARTNERS
Ampersand is a middle market private equity firm that focuses on healthcare and industrial sectors.
AMPERSAND CAPITAL PARTNERS
Social Links:
Industry:
Angel Investment Finance Financial Services Health Care Venture Capital
Founded:
1988-01-01
Status:
Active
Contact:
781-239-0700
Email Addresses:
[email protected]
Total Funding:
18.83 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Google Font API WordPress Google Analytics Google Maps Content Delivery Network IPv6
Similar Organizations
Correlation Ventures
Correlation Ventures finances early, seed, and later stage venture, and debt financing investments and is based in California.
General Catalyst
General Catalyst is a venture capital firm that provides early-stage and growth equity investments.
GSR Ventures
GSR Ventures focuses on early-stage technology companies developing AI-enabled technology.
Inovia Capital
Inovia Capital is a venture capital firm that partners with founders to build impactful and enduring global companies.
NewSpring
NewSpring Capital is focused on leveraging operational expertise and capital to build market leading companies.
Peregrine Systems
Peregrine Systems provides enterprise software worldwide. It offers information technology (IT) asset and service management software
Ribbit Capital
Ribbit Capital is a venture capital firm that invests in early-stage companies.
Sequoia Capital
Sequoia Capital is a VC firm that invests in startups in the energy, financial, enterprise, healthcare, internet, and mobile industries.
Speedinvest
Speedinvest is a venture capital fund investing in pre-seed, seed, and early-stage tech startups.
Sutter Hill Ventures
Sutter Hill Ventures primarily invests in technology-based start-ups.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2024-03-19 | Biologos | Biologos acquired by Ampersand Capital Partners | N/A |
| 2024-03-13 | Specac | Specac acquired by Ampersand Capital Partners | N/A |
| 2022-09-28 | Iuvo | Iuvo acquired by Ampersand Capital Partners | N/A |
| 2022-08-30 | AcuraBio | AcuraBio acquired by Ampersand Capital Partners | N/A |
| 2022-08-25 | Phosphorex | Phosphorex acquired by Ampersand Capital Partners | N/A |
| 2021-07-01 | ProtaGene | ProtaGene acquired by Ampersand Capital Partners | 40 M USD |
| 2021-01-05 | Genezen Laboratories | Genezen Laboratories acquired by Ampersand Capital Partners | N/A |
| 2020-09-21 | ALPCO Diagnostics | ALPCO Diagnostics acquired by Ampersand Capital Partners | N/A |
| 2020-09-21 | GeneWerk | GeneWerk acquired by Ampersand Capital Partners | N/A |
| 2019-05-29 | Vibalogics | Vibalogics acquired by Ampersand Capital Partners | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-11-28 | Julius Clinical | Ampersand Capital Partners investment in Private Equity Round - Julius Clinical | N/A |
| 2023-11-20 | ProtaGene | Ampersand Capital Partners investment in Private Equity Round - ProtaGene | N/A |
| 2023-11-02 | Genezen | Ampersand Capital Partners investment in Venture Round - Genezen | 18.5 M USD |
| 2023-06-27 | Vernal Biosciences | Ampersand Capital Partners investment in Series A - Vernal Biosciences | 20 M USD |
| 2023-06-12 | NanoImaging Services | Ampersand Capital Partners investment in Private Equity Round - NanoImaging Services | N/A |
| 2022-06-23 | Sterling Medical Devices | Ampersand Capital Partners investment in Private Equity Round - Sterling Medical Devices | N/A |
| 2022-06-07 | AnaBios | Ampersand Capital Partners investment in Series C - AnaBios | 6.5 M USD |
| 2022-06-02 | Vernal Biosciences | Ampersand Capital Partners investment in Series A - Vernal Biosciences | 21 M USD |
| 2022-04-18 | Syft Technologies | Ampersand Capital Partners investment in Private Equity Round - Syft Technologies | N/A |
| 2022-03-01 | BioEcho Life Sciences | Ampersand Capital Partners investment in Private Equity Round - BioEcho Life Sciences | N/A |
More informations about "Ampersand Capital Partners"
Core Values | Ampersand
Founded in the late 1980s, Ampersand Capital Partners began investing in life sciences companies in the early 1990s. Today, Ampersand focuses exclusively on growth equity …See details»
Our Team | Ampersand
Hidde Van Kerckhoven joined Ampersand Capital Partners in 2022. Prior to joining Ampersand, he was a member of the healthcare investment team at Gimv where he was actively involved …See details»
Ampersand Capital Partners - Investments, Portfolio & Company …
Nov 28, 2023 Ampersand Capital Partners has made 7 diversity investments. Their most recent diversity investment was on Jun 12, 2023, when NanoImaging ... Blue Sky Biotech Blue Sky …See details»
Ampersand Capital Partners | GrowthCap
Founded in 1988, Ampersand Capital Partners is a middle-market private equity firm dedicated to growth-oriented investments in the healthcare sector with $3 billion of assets under …See details»
Ampersand Capital Partners - LinkedIn
Ampersand Capital Partners | 23,043 followers on LinkedIn. Forging Leaders in Healthcare & Life Sciences | Founded in 1988, Ampersand is a middle-market private equity firm with $3 billion of ...See details»
Ampersand Capital Partners - Crunchbase
Ampersand Capital Partners invests in early to late-stage biotechnology, healthcare, and pharmaceutical companies, focusing on North America, particularly in California and Vermont. Learn More. Similar Investments. CBD …See details»
Ampersand Capital Partners
ProtaGene, a leading global contract research organization (CRO) dedicated to advanced analytics for biologics and cell and gene therapies, today announced additional investment …See details»
Ampersand Capital Partners' Leadership Team Team - The Org
The leadership team at Ampersand Capital Partners has a long history of experience in the financial and accounting industries, as well as in venture capital and private equity. Many …See details»
Ampersand Capital Partners Named a Top Private Equity Firm of …
Aug 21, 2024 Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in …See details»
Ampersand Capital Partners Named a Top Private …
Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector.See details»
Ampersand Capital Partners Ranks #1 for Growth Capital Private …
May 16, 2024 Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in …See details»
Ampersand Capital Partners investment portfolio - PitchBook
Oct 23, 2024 Ampersand Capital Partners's latest investment was on 06-Nov-2024 in Avid Bioservices, a company within the BPO/Outsource Services industry. Data Transparency. …See details»
Ampersand Capital Partners Portfolio Companies - Crunchbase
Aug 20, 1999 Ampersand is a middle market private equity firm that focuses on healthcare and industrial sectors. This list of organizations invested in by Ampersand Capital Partners …See details»
Investment Criteria - Ampersand Capital
Founded 35 years ago, Ampersand Capital Partners stands as one of America’s oldest private equity firms, boasting a legacy of success in the life sciences sector. With a robust portfolio of …See details»
Genezen Receives Growth Equity Investment from Ampersand …
Jan 4, 2021 Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production, and …See details»
Avid Bioservices to be Acquired by GHO Capital Partners and …
Nov 7, 2024 Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve …See details»
News - Ampersand Capital
Nov 4, 2024 Ampersand Capital Partners Named to Inc.’s 2024 List of Founder-Friendly-Investors. Ampersand News News Read More October 29, 2024 Resolian Appoints Rob …See details»
Ampersand Capital Partners Named Top Performing Private Equity …
Jun 27, 2024 For the second consecutive year, Preqin has ranked Ampersand Capital Partners ("Ampersand") as the 'Top Performing Private Equity Fund Manager' in the Americas within …See details»
Ampersand Capital Partners Named to Inc.’s 2023 List of Founder ...
Wellesley, MA, November 6 th, 2023 — For the second consecutive year, Ampersand Capital Partners was named to Inc.’s 2023 Founder-Friendly Investors list, which honors the private …See details»